Literature DB >> 23451503

[Cellular absorption of the active ingredients in different compatibilities of gegenqinlian decoction in human intestinal Caco-2 cells].

Bo-sha Zhang1, Rui An, Yue Wang, Xin-hong Wang.   

Abstract

OBJECTIVE: To study the intestinal dynamics characteristics of puerarin and other active ingredients in Gegenqinlian decoction.
METHODS: Caco-2 cell monolayer model was used to research the transport of puerarin and baicalin, berberine hydrochloride, liquiritin when they were used in different compatibilities, meanwhile a ultra performance liquid chromato-graphic method was also developed.
RESULTS: The concentration of puerarin, haicalin, berberine hydrochloride, liqpiritin in cell culture medium was measured and the apparent permeahility coefficients (Papp) as well as percent absorption (%) from apical side to basolateral side were calculated. The absorption characteristics of the four components were different when they were used in different compatibilities. Furthermore the Papp sequence of puerarin in specific groups were puerarin-baicalin-berberine-liquiritin group > puerarin-baicalin group > puerarin-berberine > puerarin-liquiritin group > single puerarin (P < 0. 05).
CONCLUSION: The intestinal absorption dynamics process of the active ingredients in Gegenqinlian decoction changes as the change of prescription compatibilities. And the intestinal absorption characteristics of puerarin is enhanced by the use of other components.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23451503

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  2 in total

1.  LC-MS/MS determination and pharmacokinetics study of puerarin and daidzein in rat plasma after oral administration of Gegenqinlian decoction and Radix Puerariae extract.

Authors:  Yifan Zhang; Jin Yuan; Ying Wang; Yue Wang; Rui An; Xinhong Wang
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

Review 2.  Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine.

Authors:  Liang Zhang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.